What Is a Balanced Way of Anticoagulation for Efficacy and Safety in High-Risk Elderly Patients With Atrial Fibrillation?
作者信息
Kim Daehoon
机构信息
Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Korean Circ J. 2024 Jul;54(7):407-408. doi: 10.4070/kcj.2024.0170.
Abstract
摘要
相似文献
1
What Is a Balanced Way of Anticoagulation for Efficacy and Safety in High-Risk Elderly Patients With Atrial Fibrillation?对于高危老年房颤患者，实现疗效与安全性平衡的抗凝方法是什么？
Korean Circ J. 2024 Jul;54(7):407-408. doi: 10.4070/kcj.2024.0170.
2
Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly.老年人房颤：高龄患者的抗凝策略及指征
Am J Geriatr Cardiol. 2002 Nov-Dec;11(6):357-62; quiz 363-4. doi: 10.1111/j.1076-7460.2002.00070.x.
3
Stroke prevention in elderly patients with atrial fibrillation.老年房颤患者的卒中预防
Singapore Med J. 2002 Apr;43(4):198-201.
4
Efficacy and safety of anticoagulation in thyrotoxic atrial fibrillation: a systematic review and meta-analysis.抗凝治疗在甲状腺毒症性心房颤动中的疗效与安全性：一项系统评价与荟萃分析。
Endocr Connect. 2022 May 23;11(5):e220166. doi: 10.1530/EC-22-0166.
5
Anticoagulation and atrial fibrillation.抗凝与心房颤动
Herz. 1993 Feb;18(1):27-38.
6
[Anticoagulation in patients with atrial fibrillation].[心房颤动患者的抗凝治疗]
Herz. 1996 Feb;21(1):28-36.
7
Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis.颅内出血的心房颤动患者抗凝治疗的疗效与安全性：一项系统评价和荟萃分析
Front Pharmacol. 2023 Mar 9;14:1122564. doi: 10.3389/fphar.2023.1122564. eCollection 2023.
8
Efficacy and Safety of Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Undergoing Elective Surgical Procedures: A Meta-analysis.围手术期桥接抗凝在择期手术的房颤患者中的疗效和安全性：一项荟萃分析。
Clin Med Res. 2021 Mar;19(1):19-25. doi: 10.3121/cmr.2020.1546. Epub 2020 Oct 14.
9
Thromboembolic prevention in frail elderly patients with atrial fibrillation: a practical algorithm. frail 体弱的
J Am Med Dir Assoc. 2015 May 1;16(5):358-64. doi: 10.1016/j.jamda.2014.12.008. Epub 2015 Feb 11.
10
Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.在有跌倒风险的老年房颤患者中使用抗凝治疗。
Ann Pharmacother. 2008 Apr;42(4):523-32. doi: 10.1345/aph.1K498. Epub 2008 Mar 11.
本文引用的文献
1
Optimal Dose of Edoxaban for Very Elderly Atrial Fibrillation Patients at High Risk of Bleeding: The LEDIOS Registry.艾多沙班用于出血高风险高龄房颤患者的最佳剂量：LEDIOS注册研究
Korean Circ J. 2024 Jul;54(7):398-406. doi: 10.4070/kcj.2024.0084. Epub 2024 May 10.
2
Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.极低剂量与常规剂量非维生素K拮抗剂口服抗凝剂治疗出血风险增加的老年房颤患者的临床结局：一项全国性队列研究
Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):681-691. doi: 10.1093/ehjcvp/pvad058.
3
Optimal Rhythm Control Strategy in Patients With Atrial Fibrillation.心房颤动患者的最佳节律控制策略
Korean Circ J. 2022 Jul;52(7):496-512. doi: 10.4070/kcj.2022.0078.
4
Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants.当代接受口服抗凝剂治疗的房颤患者队列中性别与临床结局的关联
Korean Circ J. 2022 Aug;52(8):593-603. doi: 10.4070/kcj.2021.0399. Epub 2022 Apr 26.
5
Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.衰弱患者心房颤动抗凝治疗的有效性和安全性。
Stroke. 2022 Jun;53(6):1873-1882. doi: 10.1161/STROKEAHA.121.036757. Epub 2022 Feb 3.
6
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.低剂量依度沙班用于高龄房颤患者。
N Engl J Med. 2020 Oct 29;383(18):1735-1745. doi: 10.1056/NEJMoa2012883. Epub 2020 Aug 30.
7
2018 Korean Guideline of Atrial Fibrillation Management.2018年韩国心房颤动管理指南。
Korean Circ J. 2018 Dec;48(12):1033-1080. doi: 10.4070/kcj.2018.0339.
8
Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges.老年房颤合并症患者预防卒中的抗凝治疗：当前证据与治疗挑战
Korean Circ J. 2018 Oct;48(10):873-889. doi: 10.4070/kcj.2018.0261.
9
10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population.全国范围内非瓣膜性心房颤动的发病率、患病率和不良结局的 10 年全国健康保险数据涵盖了全体韩国人口。
Am Heart J. 2018 Aug;202:20-26. doi: 10.1016/j.ahj.2018.04.017. Epub 2018 May 1.
10
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.非维生素 K 拮抗剂口服抗凝剂在伴有肾功能障碍的心房颤动患者中的剂量调整。
J Am Coll Cardiol. 2017 Jun 13;69(23):2779-2790. doi: 10.1016/j.jacc.2017.03.600.
Zotero 插件